The Conversation (0)
In case you missed it, here is this week’s life science big news roundup.
In case you missed it, here is this week’s life science big news roundup:
Biotech:
- Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110 Percent
- Naturally Splendid’s Natera Sport(TM) Bites at Genesis Invitational PGA Tournament
To see our previous Life Science Investing Big News Roundups, please click here.
Latest News
Outlook Reports world
Featured Life Science Investing Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES